Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation

References

• Baynes JW. Chemical modification of proteins by lipids in diabetes. Clin Chem Lab Med 2003;41:1159–1165.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta 2012;1820:663–671.
   PubMed Web of Science ®Google Scholar
• Yap FYT, Kantharidis P, Coughlan MT, Slattery R, Forbes JM. Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes. Curr Drug Targets 2012;13:526–540.
   PubMed Web of Science ®Google Scholar
• Sugiyama S, Miyata T, Inagi R, Kurokawa K. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review). Int J Mol Med 1998;2:561–565.
   PubMed Web of Science ®Google Scholar
• Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, et al. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. J Pathol 2009;218:360–369.
   PubMed Web of Science ®Google Scholar
• Del Turco S, Basta G. An update on advanced glycation endproducts and atherosclerosis. Biofactors 2012;38: 266–274.
   PubMed Web of Science ®Google Scholar
• Prasad A, Bekker P, Tsimikas S. Advanced Glycation End Products and Diabetic Cardiovascular Disease. Cardiol Rev 2012;20:177–183.
   PubMed Web of Science ®Google Scholar
• Li JL, Liu DN, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective. J Neurol Sci 2012;317:1–5.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Reed T, Sultana R. Roles of 3-nitroty rosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer‘s disease. Free Radic Res 2011;45:59–72.
   PubMed Web of Science ®Google Scholar
• Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, N-(epsilon)(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996;271: 9982–9986.
   PubMed Web of Science ®Google Scholar
• Ciulla MM, Paliotti R, Carini M, Aldini G. Fibrosis, enzymatic and non-enzymatic cross-links in hypertensive heart disease. Cardiovasc Hematol Disord Drug Targets 2011.
   PubMedGoogle Scholar
• Kurien BT, Hensley K, Bachmann M, Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 2006;41:549–556.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005;15:16R–28R.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs Cell Mol Biol 1998;44:1013–1023.
   Google Scholar
• LoPachin RM, Gavin T, DeCaprio A, Barber DS. Application of the Hard and Soft, Acids and Bases (HSAB) Theory to Toxicant-Target Interactions. Chem Res Toxicol 2012;25:239–251.
   PubMed Web of Science ®Google Scholar
• Baumgart T, Hammond AT, Sengupta P, Hess ST, Holowka DA, Baird BA, Webb WW. Large-scale fluid/fluid phase separation of proteins and lipids in giant plasma membrane vesicles. Proc Natl Acad Sci U S A 2007;104: 3165–3170.
   PubMed Web of Science ®Google Scholar
• Guéraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, et al. Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 2010;44:1098–1124.
   PubMed Web of Science ®Google Scholar
• Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 2002;22:101–107.
   PubMed Web of Science ®Google Scholar
• Breyer V, Frischmann M, Bidmon C, Schemm A, Schiebel K, Pischetsrieder M. Analysis and biological relevance of advanced glycation end-products of DNA in eukaryotic cells. FEBS J 2008;275:914–925.
   PubMed Web of Science ®Google Scholar
• Pamplona R. Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity. Biochim Biophys Acta 2008;1777:1249–1262.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Takino J, Yamagishi S. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr Drug Targets 2010;11:1468–1482.
   PubMed Web of Science ®Google Scholar
• Aldini G, Dalle-Donne I, Facino RM, Milzani A, Carini M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev 2007; 27:817–868.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors Br J Pharmacol 2008;153: 6–20.
   Google Scholar
• Maillard L. Action des acides aminés sur les sucres: formation des mélanoȉdines par voie méthodique CR Acad Sci 1912;154:66–68.
   Google Scholar
• Hodge J. Chemistry of browning reactions in model systems. J Agric Food Chem 1953;1:928–943.
   Web of Science ®Google Scholar
• Kunkel HG, Wallenius G. New hemoglobin in normal adult blood. Science 1955;122:288.
   PubMed Web of Science ®Google Scholar
• Monnier VM, Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981;211:491–493.
   PubMed Web of Science ®Google Scholar
• Tessier FJ. The Maillard reaction in the human body. The main discoveries and factors that affect glycation Pathol Biol 2010;58:214–219.
   Google Scholar
• Sell DR, Monnier VM. Molecular basis of arterial stiffening: role of glycation- A mini-review. Gerontology 2012;58: 227–237.
   PubMed Web of Science ®Google Scholar
• Goh S-Y, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143–1152.
   PubMed Web of Science ®Google Scholar
• Nagaraj RH, Linetsky M, Stitt AW. The pathogenic role of Maillard reaction in the aging eye. Amino Acids 2012;42:1205–1220.
   PubMed Web of Science ®Google Scholar
• Schalkwijk CG, Brouwers O, Stehouwer CDA. Modulation of insulin action by advanced glycation endproducts: a new player in the field. Horm Metab Res 2008;40:614–619.
   PubMed Web of Science ®Google Scholar
• Amadori M. The product of the condensation of glucose and p-phenetidine. Atti Reale Accad Nazl Lincei 1929;9: 68–73.
   Google Scholar
• Isbell H, Frush H. Mutarotation, hydrolysis, and rearrangement reactions of glycosylamines. J Org Chem 1958;23: 1309–1319.
   Web of Science ®Google Scholar
• Morales FJ, Somoza V, Fogliano V. Physiological relevance of dietary melanoidins. Amino Acids 2012;42:1097–1109.
   PubMed Web of Science ®Google Scholar
• Heyns K, Beilfuss W. Ketosylamine rearrangement of D-threo-pentulose (D-xylulose) with alpha-amino acids. Chem Ber 1970;103:2873–2876.
   PubMedGoogle Scholar
• Zeitsch K. The chemistry and technology of furfural and its many by-products. Amsterdam: Elsevier; 2000.
   Google Scholar
• Abraham K, Gurtler R, Berg K, Heinemeyer G, Lampen A, Appel KE. Toxicology and risk assessment of 5-Hydroxymethylfurfural in food. Mol Nutr Food Res 2011; 55:667–678.
   PubMed Web of Science ®Google Scholar
• Nursten H. Maillard reaction: chemistry, biochemistry and implications. London: Royal Society of Chemistry; 2005.
   Google Scholar
• Kurata T, Otsuka Y. Amino-reductones. Formation mechanisms and structural characteristics. Adv Exp Med Biol 1998;434:269–276.
   PubMed Web of Science ®Google Scholar
• Slaughter JC. The naturally occurring furanones: formation and function from pheromone to food. Biol Rev Camb Philos Soc 1999;74:259–276.
   PubMed Web of Science ®Google Scholar
• Davidek T, Robert F, Devaud S, Vera FA, Blank I. Sugar fragmentation in the Maillard reaction cascade: Formation of short-chain carboxylic acids by a new oxidative alpha-dicarbonyl cleavage pathway. J Agric Food Chem 2006;54:6677–6684.
   PubMed Web of Science ®Google Scholar
• Cammerer B, Wedzicha BL, Kroh LW. Nonenzymatic browning reactions of retro-aldol degradation products of carbohydrates. Eur Food Res Technol 1999;209:261–265.
   Web of Science ®Google Scholar
• Namiki M, Hayashi T. A new mechanism of the Maillard reaction involving sugar fragmentation and free radical formation. Washington, DC: American Chemical Society; 1983.
   Google Scholar
• Hayase F, Usui T, Ono Y, Shirahashi Y, Machida T, Ito T, et al. Formation mechanisms of melanoidins and fluorescent pyridinium compounds as advanced glycation end products. Ann N Y Acad Sci 2008;1126:53–58.
   PubMed Web of Science ®Google Scholar
• Wang HY, Qian H, Yao WR. Melanoidins produced by the Mail lard reaction: structure and biological activity. Food Chem 2011;128:573–584.
   Web of Science ®Google Scholar
• Bunn HF, Higgins PJ. Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981; 213:222–224.
   PubMed Web of Science ®Google Scholar
• Laroque D, Inisan C, Berger C, Vouland E, Dufosse L, Guerard F. Kinetic study on the Maillard reaction. Consideration of sugar reactivity Food Chem 2008;111:1032–1042.
   Web of Science ®Google Scholar
• Suárez G, Rajaram R, Oronsky AL, Gawinowicz MA. Nonenzymatic glycation of bovine serum-albumin by fructose (fructation) - comparison with the maillard reaction initiated by glucose. J Biol Chem 1989;264:3674–3679.
   PubMed Web of Science ®Google Scholar
• Dills WL. Protein fructosylation – fructose and the maillard reaction. Am J Clin Nutr 1993;58:S779–S787.
   PubMed Web of Science ®Google Scholar
• Schalkwijk CG, Stehouwer CDA, van Hinsbergh VWM. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev 2004;20: 369–382.
   PubMed Web of Science ®Google Scholar
• Rippe JM, Angelopoulos TJ. Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know?Adv Nutr 2013;4:236–245.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ho CT. Formation of 2,5-dimethyl-4-hydroxy-3(2H)-furanone through methylglyoxal: A Maillard reaction intermediate. J Agric Food Chem 2008;56:7405–7409.
   PubMed Web of Science ®Google Scholar
• Noda Y, Peterson DG. Structure-reactivity relationships of flavan-3-ols on product generation in aqueous glucose/glycine model systems. J Agric Food Chem 2007;55:3686–3691.
   PubMed Web of Science ®Google Scholar
• Nishibori S, Berhnard RA, Osawa T, Kawakishi S. Volatile components formed from reaction of sugar and beta-alanine as a model system of cookie processing. Adv Exp Med Biol 1998;434:255–267.
   PubMed Web of Science ®Google Scholar
• Ota M, Kohmura M, Kawaguchi H. Characterization of a new Maillard type reaction product generated by heating 1-deoxymaltulosyl-glycine in the presence of cysteine. J Agric Food Chem 2006;54:5127–5131.
   PubMed Web of Science ®Google Scholar
• Choudhary V, Mushrif SH, Ho C, Anderko A, Nikolakis V, Marinkovic NS, et al. Insights into the interplay of Lewis and Brønsted acid catalysts in glucose and fructose conversion to 5-(hydroxymethyl)furfural and levulinic acid in aqueous media. J Am Chem Soc 2013;135:3997–4006.
   PubMed Web of Science ®Google Scholar
• Rabbani N, Thornalley PJ. Glycation research in amino acids: a place to call home. Amino Acids 2012;42:1087–1096.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Roman G, Yeboah F, Konishi Y. The road to advanced glycation end products: a mechanistic perspective. Curr Med Chem 2007;14:1653–1671.
   PubMed Web of Science ®Google Scholar
• Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients 2010; 2:1247–1265.
   PubMed Web of Science ®Google Scholar
• Van Lancker F, Adams A, De Kimpe N. Chemical modifications of peptides and their impact on food properties. Chem Rev 2011;111:7876–7903.
   PubMed Web of Science ®Google Scholar
• Henle T. AGEs in foods: do they play a role in uremia?Kidney Int 2003;63:S145–S147.
   Web of Science ®Google Scholar
• Sebekova K, Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects – PRO. Mol Nutr Food Res 2007;51:1079–1084.
   PubMed Web of Science ®Google Scholar
• Henle T, Schwarzenbolz U, Klostermeyer H. Detection and quantification of pentosidine in foods. Z Lebensm Unters Forsch 1997;204:95–98.
   Google Scholar
• Biemel KM, Buhler HP, Reihl O, Lederer MO. Identification and quantitative evaluation of the lysine-arginine crosslinks GODIC, MODIC, DODIC, and glucosepan in foods. Nahrung 2001;45:210–214.
   PubMedGoogle Scholar
• Erbersdobler HF, Somoza V. Forty years of furosine – Forty years of using Maillard reaction products as indicators of the nutritional quality of foods. Mol Nutr Food Res 2007;51: 423–430.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ho CT. Flavour chemistry of methylglyoxal and glyoxal. Chem Soc Rev 2012;41:4140–4149.
   PubMed Web of Science ®Google Scholar
• Avzianova E, Brooks SD. Raman spectroscopy of glyoxal oligomers in aqueous solutions. Spectrochim Acta A Mol Biomol Spectrosc 2013;101:40–48.
   PubMed Web of Science ®Google Scholar
• Kielhorn J, Pohlenz-Michel C, Schmidt S. Glyoxal. Concise international chemical assessment. Geneva, Switzerland: World Health Organization; 2004.
   Google Scholar
• Degen J, Hellwig M, Henle T. 1,2-dicarbonyl compounds in commonly consumed foods. J Agric Food Chem 2012; 60:7071–7079.
   PubMed Web of Science ®Google Scholar
• Fu TM, Jacob DJ, Wittrock F, Burrows JP, Vrekoussis M, Henze DK. Global budgets of atmospheric glyoxal and methylglyoxal, and implications for formation of secondary organic aerosols. J Geophys Res Atmos 2008;113.
   PubMed Web of Science ®Google Scholar
• O’Brien PJ, Siraki AG, Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 2005;35:609–662.
   PubMed Web of Science ®Google Scholar
• Manini P, La Pietra P, Panzella L, Napolitano A, d’Ischia M. Glyoxal formation by Fenton-induced degradation of carbohydrates and related compounds. Carbohydr Res 2006;341: 1828–1833.
   PubMed Web of Science ®Google Scholar
• Wellsknecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation – identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995;34:3702–3709.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999;344:109–116.
   PubMed Web of Science ®Google Scholar
• Yin HY, Porter NA. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid Redox Signal 2005;7:170–184.
   PubMed Web of Science ®Google Scholar
• Shangari N, O’Brien PJ. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol 2004;68: 1433–1442.
   PubMed Web of Science ®Google Scholar
• Mannervik B. Molecular enzymology of the glyoxalase system. Drug Metabol Drug Interact 2008;23:13–27.
   PubMedGoogle Scholar
• Shangari N, Bruce WR, Poon R, O’Brien PJ. Toxicity of glyoxals – role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans 2003;31: 1390–1393.
   PubMed Web of Science ®Google Scholar
• Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 2010;183:2244–2248.
   PubMed Web of Science ®Google Scholar
• Lange JN, Wood KD, Knight J, Assimos DG, Holmes RP. Glyoxal formation and its role in endogenous oxalate synthesis. Adv Urol 2012;2012:819202.
   PubMedGoogle Scholar
• Thornalley PJ. Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D- lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptorCrit Rev Oncol Hematol 1995;20:99–128.
   PubMed Web of Science ®Google Scholar
• Schwarzenbolz U, Henle T, Haebner R, Klostermeyer A. On the reaction of glyoxal with proteins. Z Lebensm Unters Forsch 1997;205:121–124.
   Google Scholar
• Zeng JM, Davies MJ. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem Res Toxicol 2005;18:1232–1241.
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Steventon GB. S-Carboxymethyl-L-cysteine. Drug Metab Rev 2012;44:129–147.
   PubMed Web of Science ®Google Scholar
• Glomb MA, Lang G. Isolation and characterization of glyoxal-arginine modifications. J Agric Food Chem 2001; 49:1493–1501.
   PubMed Web of Science ®Google Scholar
• Iijima K, Murata M, Takahara H, Irie S, Fujimoto D. Identification of N(omega)-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen. Biochem J 2000;347:23–27.
   PubMed Web of Science ®Google Scholar
• Cotham WE, Metz TO, Ferguson PL, Brock JWC, Hinton DJS, Thorpe SR, et al. Proteomic analysis of arginine adducts on glyoxal-modified ribonuclease. Mol Cell Proteomics 2004;3:1145–1153.
   PubMed Web of Science ®Google Scholar
• Schwarzenbolz U, Mende S, Henle T. Model studies on protein glycation: influence of cysteine on the reactivity of arginine and lysine residues toward glyoxal. Ann N Y Acad Sci 2008;1126:248–252.
   PubMed Web of Science ®Google Scholar
• Sell DR, Monnier VM. Conversion of arginine into ornithine by advanced glycation in senescent human collagen and lens crystallins. J Biol Chem 2004;279:54173–54184.
   PubMed Web of Science ®Google Scholar
• Lederer MO, Klaiber RG. Cross-linking of proteins by Maillard processes: characterization and detection of lysine-arginine cross-links derived from glyoxal and methylglyoxal. Bioorg Med Chem 1999;7:2499–2507.
   PubMed Web of Science ®Google Scholar
• Nasiri R, Field MJ, Zahedi M, Moosavi-Movahedi AA. Cross-linking mechanisms of arginine and lysine with α,β-dicarbonyl compounds in aqueous solution. J Phys Chem A 2011;115:13542–13555.
   PubMed Web of Science ®Google Scholar
• Adamiec J, Rossner J, Velisek J, Cejpek K, Savel J. Minor Strecker degradation products of phenylalanine and phenylglycine. Eur Food Res Technol 2001;212:135–140.
   Web of Science ®Google Scholar
• Glomb MA, Pfahler C. Amides are novel protein modifications formed by physiological sugars. J Biol Chem 2001; 276:41638–41647.
   PubMed Web of Science ®Google Scholar
• Pfeifer YV, Haase PT, Kroh LW. Reactivity of thermally treated α-dicarbonyl compounds. J Agric Food Chem 2013;61:3090–3096.
   PubMed Web of Science ®Google Scholar
• Nemet I, Varga-Defterdarovic L. Methylglyoxal-derived beta-carbolines formed from tryptophan and its derivates in the Maillard reaction. Amino Acids 2007;32:291–293.
   PubMed Web of Science ®Google Scholar
• HomokiFarkas P, Orsi F, Kroh LW. Methylglyoxal determination from different carbohydrates during heat processing. Food Chem 1997;59:157–163.
   Web of Science ®Google Scholar
• Hollnagel A, Kroh L. Formation of α-dicarbonyl fragments from mono- and disaccharides under caramelization and Maillard reaction conditions. Z Lebensm Unters Forsch 1998;207:50–54.
   Google Scholar
• Kuntz S, Rudloff S, Ehl J, Bretzel RG, Kunz C. Food derived carbonyl compounds affect basal and stimulated secretion of interleukin-6 and-8 in Caco-2 cells. Eur J Nutr 2009;48:499–503.
   PubMed Web of Science ®Google Scholar
• Casazza JP, Felver ME, Veech RL. The metabolism of acetone in rat. J Biol Chem 1984;259:231–236.
   PubMed Web of Science ®Google Scholar
• Cooper R. Metabolism of methylglyoxal in microorganisms. Annu Rev Microbiol 1984;38:49–68.
   PubMed Web of Science ®Google Scholar
• Fujioka K, Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol 2006;21: 47–54.
   PubMed Web of Science ®Google Scholar
• Camel V, Bermond A. The use of ozone and associated oxidation processes in drinking water treatment. Water Res 1998;32:3208–3222.
   Web of Science ®Google Scholar
• Beisswenger PJ, Howell SK, Nelson RG, Mauer M, Szwergold BS. alpha-oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 2003;31:1358–1363.
   PubMed Web of Science ®Google Scholar
• Kalapos MP. Methylglyoxal in living organisms – Chemistry, biochemistry, toxicology and biological implications. Toxicol Lett 1999;110:145–175.
   PubMed Web of Science ®Google Scholar
• Kalapos M. Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research. Drug Metabol Drug Interact 2008;23:69–91.
   PubMedGoogle Scholar
• Kalapos MP. The tandem of free radicals and methylglyoxal. Chem Biol Interact 2008;171:251–271.
   PubMed Web of Science ®Google Scholar
• Cui Q, Karplus M. Catalysis and specificity in enzymes: a study of triosephosphate isomerase and comparison with methyl glyoxal synthase. Adv Protein Chem 2003;66: 315–372.
   PubMedGoogle Scholar
• Richard JP. Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans 1993;21:549–553.
   PubMed Web of Science ®Google Scholar
• Cooper RA. Methylglyoxal synthase. Methods Enzymol 1975;41:502–508.
   PubMedGoogle Scholar
• Dhar A, Desai K, Kazachmov M, Yu P, Wu LY. Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism 2008;57: 1211–1220.
   PubMed Web of Science ®Google Scholar
• Bondoc FY, Bao ZP, Hu WY, Gonzalez FJ, Wang YY, Yang CS, Hong JY. Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochem Pharmacol 1999;58:461–463.
   PubMed Web of Science ®Google Scholar
• Turk Z, Nemet I, Varga-Defteardarovic L, Car N. Elevated level of methylglyoxal during diabetic ketoacidosis and its recovery phase. Diabetes Metab 2006;32:176–180.
   PubMed Web of Science ®Google Scholar
• Jung JY, Yun HS, Lee J, Oh MK. Production of 1,2- Propanediol from Glycerol in Saccharomyces cerevisiae. J Microbiol Biotechnol 2011;21:846–853.
   PubMed Web of Science ®Google Scholar
• Bechara EJH, Dutra F, Cardoso VES, Sartori A, Olympio KPK, Penatti CAA, et al. The dual face of endogenous alpha-aminoketones: Pro-oxidizing metabolic weapons. Comp Biochem Physiol C Toxicol Pharmacol 2007;146:88–110.
   Google Scholar
• Callingham BA, Crosbie AE, Rous BA. Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes. Prog Brain Res 1995;106:305–321.
   PubMed Web of Science ®Google Scholar
• Lyles GA. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol 1996;28:259–274.
   PubMed Web of Science ®Google Scholar
• Vander Jagt DL, Hunsaker LA. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact 2003;143–144:341–351.
   PubMed Web of Science ®Google Scholar
• Vander Jagt DL. Methylglyoxal, diabetes mellitus and diabetic complications. Drug Metabol Drug Interact 2008; 23:93–124.
   PubMedGoogle Scholar
• Yang K, Qiang D, Delaney S, Mehta R, Bruce WR, O’Brien PJ. Differences in glyoxal and methylglyoxal metabolism determine cellular susceptibility to protein carbonylation and cytotoxicity. Chem Biol Interact 2011;191:322–329.
   PubMed Web of Science ®Google Scholar
• Vedantham S, Ananthakrishnan R, Schmidt AM, Ramasamy R. Aldose reductase, oxidative stress and diabetic cardiovascular complications. Cardiovasc Hematol Agents Med Chem 2012;10:234–240.
   PubMedGoogle Scholar
• Choi CH, Park SJ, Jeong SY, Yim HS, Kang SO. Methylglyoxal accumulation by glutathione depletion leads to cell cycle arrest in Dictyostelium. Mol Microbiol 2008; 70:1293–1304.
   PubMed Web of Science ®Google Scholar
• Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008;4:697–720.
   PubMed Web of Science ®Google Scholar
• Munoz-Clares RA, Diaz-Sanchez AG, Gonzalez-Segura L, Montiel C. Kinetic and structural features of betaine aldehyde dehydrogenases: Mechanistic and regulatory implications. Arch Biochem Biophys 2010;493:71–81.
   PubMed Web of Science ®Google Scholar
• Dunkerton J, James SP. Purification of 2-oxoaldehyde dehydrogenase and its dependence on unusual amines. Biochem J 1975;149:609–617.
   PubMed Web of Science ®Google Scholar
• Degenhardt TP, Thorpe SR, Baynes JW. Chemical modification of proteins by methylglyoxal. Cell Mol Biol (Noisy- le-grand) 1998;44:1139–1145.
   PubMed Web of Science ®Google Scholar
• Westwood ME, Thornalley PJ. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins – comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Protein Chem 1995; 14:359–372.
   PubMedGoogle Scholar
• Thornalley PJ. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification – a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 1996;27:565–573.
   PubMedGoogle Scholar
• Henle T, Walter AW, Haessner R, Klostermeyer H. Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal. Z Lebensm Unters Forsch 1994;199:55–58.
   Google Scholar
• Lo TWC, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions – a kinetic and mechanistic study with n-alpha-acetylarginine, n-alpha- acetylcysteine, and n-alpha-acetyllysine, and bovine serum-albumin. J Biol Chem 1994;269:32299–32305.
   PubMed Web of Science ®Google Scholar
• Wang TN, Kartika R, Spiegel DA. Exploring Post- translational Arginine Modification Using Chemically Synthesized Methylglyoxal Hydroimidazolones. J Am Chem Soc 2012;134:8958–8967.
   PubMed Web of Science ®Google Scholar
• Klopfer A, Spanneberg R, Glomb MA. Formation of arginine modifications in a model system of N-alpha-tert- Butoxycarbonyl (Boc)-Arginine with methylglyoxal. J Agric Food Chem 2011;59:394–401.
   PubMed Web of Science ®Google Scholar
• Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T, Uchida K. Methylglyoxal modification of protein – Chemical and immunochemical characterization of methylglyoxal- arginine adducts. J Biol Chem 1999;274:18492–18502.
   PubMed Web of Science ®Google Scholar
• Shipanova IN, Glomb MA, Nagaraj RH. Protein modification by methylglyoxal: Chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 1997;344:29–36.
   PubMed Web of Science ®Google Scholar
• Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324:565–570.
   PubMed Web of Science ®Google Scholar
• Sell DR, Strauch CM, Shen W, Monnier VM. 2-Aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J 2007;404:269–277.
   PubMed Web of Science ®Google Scholar
• Nagaraj RH, Shipanova IN, Faust FM. Protein cross-linking by the Maillard reaction – Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J Biol Chem 1996;271:19338–19345.
   PubMed Web of Science ®Google Scholar
• Meade SJ, Miller AG, Gerrard JA. The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure- activity study. Bioorg Med Chem 2003;11:853–862.
   PubMed Web of Science ®Google Scholar
• Nemet I, Varga-Defterdarovic L. The role of methylglyoxal in the non-enzymatic conversion of tryptophan, its methyl ester and tryptamine to 1-acetyl-beta-carbolines. Bioorg Med Chem 2008;16:4551–4562.
   PubMed Web of Science ®Google Scholar
• Niwa T. 3-deoxyglucosone: metabolism, analysis, biological activity, and clinical implication. J Chromatogr B 1999; 731:23–36.
   PubMed Web of Science ®Google Scholar
• Usui T, Yanagisawa S, Ohguchi M, Yoshino M, Kawabata R, Kishimoto J, et al. Identification and determination of alpha-dicarbonyl compounds formed in the degradation of sugars. Biosci Biotechnol Biochem 2007;71:2465–2472.
   PubMed Web of Science ®Google Scholar
• Gobert J, Glomb MA. Degradation of glucose: reinvestigation of reactive alpha-dicarbonyl compounds. J Agric Food Chem 2009;57:8591–8597.
   PubMed Web of Science ®Google Scholar
• Andrewes P. Changes in mail lard reaction products in ghee during storage. Food Chem 2012;135:921–928.
   PubMed Web of Science ®Google Scholar
• Gensberger S, Mittelmaier S, Glomb MA, Pischetsrieder M. Identification and quantification of six major α-dicarbonyl process contaminants in high-fructose corn syrup. Anal Bioanal Chem 2012;403:2923–2931.
   PubMed Web of Science ®Google Scholar
• Jadhav H, Pedersen CM, Soiling T, Bols M. 3-Deoxy- glucosone is an intermediate in the formation of furfurals from D-glucose. Chemsuschem 2011;4:1049–1051.
   PubMed Web of Science ®Google Scholar
• Tsukushi S, Katsuzaki T, Aoyama I, Takayama F, Miyazaki T, Shimokata K, Niwa T. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway. Kidney Int 1999;55:1970–1976.
   PubMed Web of Science ®Google Scholar
• Sakai M, Oimomi M, Kasuga M. Experimental studies on the role of fructose in the development of diabetic complications. Kobe J Med Sci 2002;48:125–136.
   PubMedGoogle Scholar
• Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, Hotta N. Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun 1996;228:539–543.
   PubMed Web of Science ®Google Scholar
• Delpierre G, Collard F, Fortpied J, Van Schaftingen E. Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J 2002;365:801–808.
   PubMed Web of Science ®Google Scholar
• Lal S, Randall WC, Taylor AH, Kappler F, Walker M, Brown TR, Szwergold BS. Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts. Metabolism 1997;46:1333–1338.
   PubMed Web of Science ®Google Scholar
• Wellsknecht KJ, Lyons TJ, McCance DR, Thorpe SR, Feather MS, Baynes JW. 3-deoxyfructose concentrations are increased in human plasma and urine in diabetes. Diabetes 1994;43:1152–1156.
   PubMed Web of Science ®Google Scholar
• Collard F, Vertommen D, Fortpied J, Duester G, Van Schaftingen E. Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1). Biochimie 2007;89:369–373.
   PubMed Web of Science ®Google Scholar
• Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002;62:697–703.
   PubMed Web of Science ®Google Scholar
• Ortiz A, Wieslander A, Linden T, Santamaria B, Sanz A, Justo P, et al. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes. Curr Med Chem 2006;13:2695–2702.
   PubMed Web of Science ®Google Scholar
• Mittelmaier S, Niwa T, Pischetsrieder M. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis. J Ren Nutr 2012;22:181–185.
   PubMed Web of Science ®Google Scholar
• Jono T, Nagai R, Lin X, Ahmed N, Thornalley PJ, Takeya M, Horiuchi S. N-epsilon-(carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone. J Biochem 2004;136: 351–358.
   PubMed Web of Science ®Google Scholar
• Hayase F, Konishi Y, Kato H. Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a maillard reaction intermediate. Biosci Biotechnol Biochem 1995;59:1407–1411.
   PubMed Web of Science ®Google Scholar
• Niwa T, Katsuzaki T, Ishizaki Y, Hayase F, Miyazaki T, Uematsu T, et al. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes. Febs Lett 1997;407:297–302.
   PubMed Web of Science ®Google Scholar
• Franke S, Niwa T, Deuther-Conrad W, Sommer M, Hein G, Stein G. Immunochemical detection of imidazolone in uremia and rheumatoid arthritis. Clin Chim Acta 2000;300: 29–41.
   PubMed Web of Science ®Google Scholar
• Kroh LW, Fiedler T, Wagner J. alpha-dicarbonyl compounds – key intermediates for the formation of carbohydrate-based melanoidins. Ann N Y Acad Sci 2008;1126:210–215.
   PubMed Web of Science ®Google Scholar
• Miyata S, Liu BP, Shoda H, Ohara T, Yamada H, Suzuki K, Kasuga M. Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes. J Biol Chem 1997;272:4037–4042.
   PubMed Web of Science ®Google Scholar
• Monnier VM, Nagaraj RH, PorteroOtin M, Glomb M, Elgawish AH, Sell DR, Friedlander MA. Structure of advanced Maillard reaction products and their pathological role. Nephrol Dial Transplant 1996;11:20–26.
   PubMed Web of Science ®Google Scholar
• Hellwig M, Henle T. Formyline, a new glycation compound from the reaction of lysine and 3-deoxypentosone. Eur Food Res Technol 2010;230:903–914.
   Web of Science ®Google Scholar
• Hidalgo FJ, Zamora R. In-vitro production of long-chain pyrrole fatty esters from carbonyl-amine reactions. J Lipid Res 1995;36:725–735.
   PubMed Web of Science ®Google Scholar
• Nagaraj RH, PorteroOtin M, Monnier VM. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes. Arch Biochem Biophys 1996;325:152–158.
   PubMed Web of Science ®Google Scholar
• Geissler S, Hellwig M, Zwarg M, Markwardt F, Henle T, Brandsch M. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1. J Agric Food Chem 2010;58:2543–2547.
   PubMed Web of Science ®Google Scholar
• Niwa H, Takeda A, Wakai M, Miyata T, Yasuda Y, Mitsuma T, et al. Accelerated formation of N-epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun 1998;248:93–97.
   PubMed Web of Science ®Google Scholar
• Skovsted IC, Christensen M, Breinholt J, Mortensen SB. Characterisation of a novel AGE-compound derived from lysine and 3-deoxyglucosone. Cell Mol Biol 1998;44:1159–1163.
   PubMed Web of Science ®Google Scholar
• Dai ZY, Wang BL, Sun G, Fan XJ, Anderson VE, Monnier VM. Identification of glucose-derived cross-linking sites in ribonuclease A. J Proteome Res 2008;7:2756–2768.
   PubMed Web of Science ®Google Scholar
• Biemel KM, Friedl DA, Lederer MO. Identification and quantification of major Maillard cross-links in human serum albumin and lens protein – evidence for glucosepane as the dominant compound. J Biol Chem 2002;277:24907–24915.
   PubMed Web of Science ®Google Scholar
• Reihl O, Biemel KM, Eipper W, Lederer MO, Schwack W. Spiro cross-links: Representatives of a new class of glycoxidation products. J Agric Food Chem 2003;51:4810–4818.
   PubMed Web of Science ®Google Scholar
• Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans 2003;31:1423–1425.
   PubMed Web of Science ®Google Scholar
• Krause R, Schlegel K, Schwarzer E, Henle T. Formation of peptide-bound Heyns compounds. J Agric Food Chem 2008;56:2522–2527.
   PubMed Web of Science ®Google Scholar
• Reihl O, Rothenbacher TM, Lederer MO, Schwack W. Carbohydrate carbonyl mobility – the key process in the formation of alpha-dicarbonyl intermediates. Carbohydr Res 2004;339:1609–1618.
   PubMed Web of Science ®Google Scholar
• Hartkopf J, Erbersdobler HF. Model experiments on the formation of N-epsilon-carboxymethyllysine in food-products. Z Lebensm Unters Forsch 1994;198:15–19.
   PubMedGoogle Scholar
• Sjoberg JS, Bulterijs S. Characteristics, formation, and pathophysiology of glucosepane: a major protein cross-link. Rejuvenation Res 2009;12:137–148.
   PubMed Web of Science ®Google Scholar
• Nasiri R, Field MJ, Zahedi M, Moosavi-Movahedi AA. Comparative DFT study to determine if α-oxoaldehydes are precursors for pentosidine formation. J Phys Chem A 2012; 116:2986–2996.
   PubMed Web of Science ®Google Scholar
• Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM. Glucosepane is a major protein cross-link of the senescent human extracellular matrix – relationship with diabetes. J Biol Chem 2005;280:12310–12315.
   PubMed Web of Science ®Google Scholar
• Fan XJ, Sell DR, Zhang JY, Nemet I, Theves M, Lu J, et al. Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysis. Free Radic Biol Med 2010;49:847–856.
   Google Scholar
• Grandhee SK, Monnier VM. Mechanism of formation of the maillard protein cross-link pentosidine – glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem 1991;266:11649–11653.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Hayase F, Kato H. Formation of ϵ-(2-formyl- 5-hydroxymethyl-pyrrol-1-yl)-L-norleucine in the Maillard reaction between D-glucose and L-lysine. Agric Biol Chem 1980;44:1201–1202.
   Web of Science ®Google Scholar
• Requena JR, Price DL, Thorpe SR, Baynes JW. Measurement of pentosidine in biological samples. Methods Mol Med 2000;38:209–217.
   PubMedGoogle Scholar
• Biemel KM, Reihl O, Conrad J, Lederer MO. Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes – Unraveling the structure of a pentosidine precursor. J Biol Chem 2001; 276:23405–23412.
   PubMed Web of Science ®Google Scholar
• Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of proteins by glucose - identification of glucose and other carbohydrates as possible precursors of pentosidine invivo. J Biol Chem 1991;266:11654–11660.
   PubMed Web of Science ®Google Scholar
• Nasiri R, Zahedi M, Jamet H, Moosavi-Movahedi AA. Theoretical studies on models of lysine-arginine cross-links derived from α-oxoaldehydes: a new mechanism for glucosepane formation. J Mol Model 2012;18:1645–1659.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Nakazawa Y, Ienaga K. Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 1997;232:227–230.
   PubMed Web of Science ®Google Scholar
• Tessier F, Obrenovich M, Monnier VM. Structure and mechanism of formation of human lens fluorophore LM-1 – relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. J Biol Chem 1999;274:20796–20804.
   PubMed Web of Science ®Google Scholar
• Nemet I, Strauch CM, Monnier VM. Favored and disfavored pathways of protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus glucosepane. Amino Acids 2011;40:167–181.
   PubMed Web of Science ®Google Scholar
• Obayashi H, Nakano K, Shigeta H, Yamaguchi M, Yoshimori K, Fukui M, et al. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 1996;226:37–41.
   PubMed Web of Science ®Google Scholar
• Pamplona R. Advanced lipoxidation end-products. Chem Biol Interact 2011;192:14–20.
   PubMed Web of Science ®Google Scholar
• Hermetter A, Kinnunen P, Spickett C. Oxidized phospholipids-Their properties and interactions with proteins. Biochim Biophys Acta 2012;1818:2373–2373.
   PubMed Web of Science ®Google Scholar
• Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, Stockl J. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 2010;12:1009–1059.
   PubMed Web of Science ®Google Scholar
• Hoff HF, O’Neil J, Wu ZP, Hoppe G, Salomon RL. Phospholipid hydroxyalkenals - Biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2003;23: 275–282.
   PubMed Web of Science ®Google Scholar
• Silva AMN, Borralho AC, Pinho SA, Domingues MRM, Domingues P. Cross-oxidation of angiotensin II by glycerophosphatidylcholine oxidation products. Rapid Commun Mass Spectrom 2011;25:1413–1421.
   PubMed Web of Science ®Google Scholar
• Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-deoxy-Delta(12,14)-prostaglandin J(2) – a prostaglandin D-2 metabolite generated during inflammatory processes. J Biol Chem 2002;277:10459–10466.
   PubMed Web of Science ®Google Scholar
• Garzon B, Oeste CL, Diez-Dacal B, Perez-Sala D. Proteomic studies on protein modification by cyclopentenone prostaglandins: Expanding our view on electrophile actions. J Proteomics 2011;74:2243–2263.
   PubMed Web of Science ®Google Scholar
• Schneider C, Porter NA, Brash AR. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 2008;283:15539–15543.
   PubMed Web of Science ®Google Scholar
• Long EK, Picklo MJ, Sr. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: Make some room HNE. Free Radic Biol Med 2010;49:1–8.
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation: Physiological levels and dual biological effects. Free Radic Biol Med 2009;47:469–484.
   PubMed Web of Science ®Google Scholar
• Szori M, Abou-Abdo T, Fittschen C, Csizmadia IG, Viskolcz B. Allylic H-abstraction hydrogen abstraction from 1,4 type polyalkenes as a model for free radical trapping by polyunsaturated fatty acids (PUFAs). Phys Chem Chem Phys 2007;9:1931–1940.
   PubMed Web of Science ®Google Scholar
• Catala A. A synopsis of the process of lipid peroxidation since the discovery of the essential fatty acids. Biochem Biophys Res Commun 2010;399:318–323.
   PubMed Web of Science ®Google Scholar
• Stevens JF, Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 2008;52:7–25.
   PubMed Web of Science ®Google Scholar
• Seiler N. Catabolism of polyamines. Amino Acids 2004; 26:217–233.
   PubMed Web of Science ®Google Scholar
• Balogh LM, Atkins WM. Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metab Rev 2011;43:165–178.
   PubMed Web of Science ®Google Scholar
• Alary J, Gueraud F, Cravedi JP. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol Aspects Med 2003;24:177–187.
   PubMedGoogle Scholar
• Kuiper HC, Miranda CL, Sowell JD, Stevens JF. Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2- nonenal metabolites are in vivo markers of oxidative stress. J Biol Chem 2008;283:17131–17138.
   PubMed Web of Science ®Google Scholar
• Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 2003;24: 281–291.
   PubMedGoogle Scholar
• Jaganjac M, Prah IO, Cipak A, Cindric M, Mrakovcic L, Tatzber F, et al. Effects of bioreactive acrolein from automotive exhaust gases on human cells in vitro. Environ Toxicol 2012;27:644–652.
   PubMed Web of Science ®Google Scholar
• Abraham K, Andres S, Palavinskas R, Berg K, Appel KE, Lampen A. Toxicology and risk assessment of acrolein in food. Mol Nutr Food Res 2011;55:1277–1290.
   PubMed Web of Science ®Google Scholar
• Liu L, Ye XP, Bozell JJ. A comparative review of petroleum-based and bio-based acrolein production. Chemsuschem 2012;5:1162–1180.
   PubMed Web of Science ®Google Scholar
• Arntz D, Fischer A, Höpp M, Jacobi S, Sauer J, Ohara T, et al. Acrolein and Methacrolein. Ullmann’s Encyclopedia of Industrial Chemistry. New York: Wiley; 2007.
   Google Scholar
• Bein K, Leikauf GD. Acrolein – a pulmonary hazard. Mol Nutr Food Res 2011;55:1342–1360.
   PubMed Web of Science ®Google Scholar
• Talhout R, Opperhuizen A, van Amsterdam JGC. Sugars as tobacco ingredient: Effects on mainstream smoke composition. Food Chem Toxicol 2006;44:1789–1798.
   PubMed Web of Science ®Google Scholar
• Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, Hecht SS. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol 2009;22:734–741.
   PubMed Web of Science ®Google Scholar
• LoPachin RM, Gavin T, Petersen DR, Barber DS. Molecular mechanisms of 4-hydroxy-2-nonenal and Acrolein Toxicity: Nucleophilic Targets and Adduct Formation. Chem Res Toxicol 2009;22:1499–1508.
   PubMed Web of Science ®Google Scholar
• Nadkarni DV, Sayre LM. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem Res Toxicol 1995;8:284–291.
   PubMed Web of Science ®Google Scholar
• Lin D, Lee HG, Liu Q, Perry G, Smith MA, Sayre LM. 4-oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem Res Toxicol 2005;18:1219–1231.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Sayre LM, Lin D, Yuan Q, Zhu XC, Tang XX. Protein adducts generated from products of lipid oxidation: Focus on HNE and ONE. Drug Metab Rev 2006;38: 651–675.
   PubMed Web of Science ®Google Scholar
• Uchida K, Stadtman ER. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase - a possible involvement of intramolecular and intermole- cular cross-linking reaction. J Biol Chem 1993;268: 6388–6393.
   PubMed Web of Science ®Google Scholar
• Lee SH, Blair IA. Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem Res Toxicol 2000;13:698–702.
   PubMed Web of Science ®Google Scholar
• Spiteller P, Kern W, Reiner J, Spiteller G. Aldehydic lipid peroxidation products derived from linoleic acid. Biochim Biophys Acta 2001;1531:188–208.
   PubMed Web of Science ®Google Scholar
• Liu ZF, Minkler PE, Sayre LA. Mass spectroscopic characterization of protein modification by 4-Hydroxy-2-(E)- nonenal and 4-Oxo-2-(E)-nonenal. Chem Res Toxicol 2003; 16:901–911.
   PubMed Web of Science ®Google Scholar
• Zhang WH, Liu JY, Xu GZ, Yuan Q, Sayre LM. Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem Res Toxicol 2003;16:512–523.
   PubMed Web of Science ®Google Scholar
• Zhu XC, Sayre LM. Mass spectrometric evidence for long-lived protein adducts of 4-oxo-2-nonenal. Redox Rep 2007; 12:45–49.
   PubMed Web of Science ®Google Scholar
• Doorn JA, Petersen DR. Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem Biol Interact 2003;143:93–100.
   PubMed Web of Science ®Google Scholar
• Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 1999;9:109–113.
   PubMed Web of Science ®Google Scholar
• Furuhata A, Ishii T, Kumazawa S, Yamada T, Nakayama T, Uchida K. N-epsilon-(3-methylpyridinium) lysine, a major antigenic adduct generated in acrolein-modified protein. J Biol Chem 2003;278:48658–48665.
   PubMed Web of Science ®Google Scholar
• Maeshima T, Honda K, Chikazawa M, Shibata T, Kawai Y, Akagawa M, Uchida K. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N-tau-(3-Propanal)histidine as the major adduct. Chem Res Toxicol 2012;25:1384–1392.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15:316–328.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li W, Li T. Generation and detection of levuglandins and isolevuglandins in vitro and in vivo. Molecules 2011;16:5333–5348.
   PubMed Web of Science ®Google Scholar
• Davies SS, Amarnath V, Roberts LJ. Isoketals: highly reactive gamma-ketoaldehydes formed from the H-2-isoprostane pathway. Chem Phys Lipids 2004;128:85–99.
   PubMed Web of Science ®Google Scholar
• Salomon RG. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways. Chem Phys Lipids 2005;134:1–20.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes P, Jackson Roberts L. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007; 14:703–717.
   PubMed Web of Science ®Google Scholar
• Doureradjou P, Koner BC. Effect of different cooking vessels on heat induced lipid peroxidation of different edible oils. J Food Biochem 2008;32:740–751.
   Web of Science ®Google Scholar
• Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000;43:550–557.
   PubMed Web of Science ®Google Scholar
• Slatter DA, Murray M, Bailey AJ. Formation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems. Febs Lett 1998; 421:180–184.
   PubMed Web of Science ®Google Scholar
• Ishii T, Ito S, Kumazawa S, Sakurai T, Yamaguchi S, Mori T, et al. Site-specific modification of positively-charged surfaces on human serum albumin by malondialdehyde. Biochem Biophys Res Commun 2008;371:28–32.
   PubMed Web of Science ®Google Scholar
• Ishii T, Kumazawa S, Sakurai T, Nakayama T, Uchida K. Mass spectroscopic characterization of protein modification by malondialdehyde. Chem Res Toxicol 2006;19:122–129.
   PubMedGoogle Scholar
• Slatter DA, Paul RG, Murray M, Bailey AJ. Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 1999;274:19661–19669.
   PubMed Web of Science ®Google Scholar
• Slatter DA, Avery NC, Bailey AJ. Identification of a new cross-link and unique histidine adduct from bovine serum albumin incubated with malondialdehyde. J Biol Chem 2004;279:61–69.
   PubMed Web of Science ®Google Scholar